live
hostil
environ
surround
microbi
pathogen
subject
rang
physic
chemic
insult
surviv
environ
vertebr
evolv
complex
immun
system
key
element
defenc
deploy
rapid
respons
element
probabl
site
attack
epithelialcel
boundari
bodi
environ
skin
gut
lung
bodi
largest
expos
interfac
environ
skin
central
role
host
defenc
rel
recent
discoveri
immunolog
defenc
skin
cutan
interfac
view
passiv
barrier
host
hostil
environ
past
decad
howev
becom
appar
mechan
aspect
epiderm
defenc
reinforc
versatil
robust
system
immun
surveil
fig
crucial
role
immun
surveil
maintain
homeostasi
evid
mark
increas
frequenc
sever
cutan
malign
infect
immun
function
limit
exampl
patient
genet
acquir
immunodefici
disord
receiv
immunosuppress
therapi
organ
transplant
regul
skin
defenc
mechan
also
crucial
inappropri
misdirect
immun
activ
implic
pathogenesi
larg
varieti
acquir
inflammatori
skin
disord
includ
psoriasi
atop
allerg
contact
dermat
lichen
planu
alopecia
areata
vitiligo
role
immun
dysfunct
condit
emphas
respons
immunosuppress
therapeut
intervent
understand
mechan
immun
surveil
skin
tissuespecif
immun
respons
also
import
implic
ration
design
vaccin
promot
protect
immun
immun
protocol
must
elicit
antigenspecif
immun
respons
also
effect
memori
respons
provid
longliv
protect
probabl
site
invas
appli
equal
immun
infecti
organ
case
invad
skin
epithelia
gastrointestin
respiratori
system
elicit
immun
respons
tumour
discuss
rout
mean
adjuv
stimul
use
affect
effect
util
specif
vaccin
strategi
review
discuss
issu
context
recent
advanc
understand
cutan
immun
mechan
highlight
interact
skin
primari
interfac
bodi
environ
provid
first
line
defenc
broad
array
microbi
pathogen
trauma
addit
properti
physic
barrier
skin
mani
activ
defenc
mechan
review
discuss
interact
innat
adapt
immun
system
skin
model
immun
function
epithelialcel
interfac
environ
mechan
account
robust
natur
cutan
immun
surveil
dysregul
drive
pathogenesi
inflammatori
skin
disord
skinbas
tumour
subject
review
live
hostil
environ
surround
microbi
pathogen
subject
rang
physic
chemic
insult
surviv
environ
vertebr
evolv
complex
immun
system
key
element
defenc
deploy
rapid
respons
element
probabl
site
attack
epithelialcel
boundari
bodi
environ
skin
gut
lung
bodi
largest
expos
interfac
environ
skin
central
role
host
defenc
rel
recent
discoveri
immunolog
defenc
skin
cutan
interfac
view
passiv
barrier
host
hostil
environ
past
decad
howev
becom
appar
mechan
aspect
epiderm
defenc
reinforc
versatil
robust
system
immun
surveil
fig
crucial
role
immun
surveil
maintain
homeostasi
evid
mark
increas
frequenc
sever
cutan
malign
infect
immun
function
limit
exampl
patient
genet
acquir
immunodefici
disord
receiv
immunosuppress
therapi
organ
transplant
regul
skin
defenc
mechan
also
crucial
inappropri
misdirect
immun
activ
implic
pathogenesi
larg
varieti
acquir
inflammatori
skin
disord
includ
psoriasi
atop
allerg
contact
dermat
lichen
planu
alopecia
areata
vitiligo
role
immun
dysfunct
condit
emphas
respons
immunosuppress
therapeut
intervent
understand
mechan
immun
surveil
skin
tissuespecif
immun
respons
also
import
implic
ration
design
vaccin
promot
protect
immun
immun
protocol
must
elicit
antigenspecif
immun
respons
also
effect
memori
respons
provid
longliv
protect
probabl
site
invas
appli
equal
immun
infecti
organ
case
invad
skin
epithelia
gastrointestin
respiratori
system
elicit
immun
respons
tumour
discuss
rout
mean
adjuv
stimul
use
affect
effect
util
specif
vaccin
strategi
review
discuss
issu
context
recent
advanc
understand
cutan
immun
mechan
highlight
interact
skin
primari
interfac
bodi
environ
provid
first
line
defenc
broad
array
microbi
pathogen
trauma
addit
properti
physic
barrier
skin
mani
activ
defenc
mechan
review
discuss
interact
innat
adapt
immun
system
skin
model
immun
function
epithelialcel
interfac
environ
mechan
account
robust
natur
cutan
immun
surveil
dysregul
drive
pathogenesi
inflammatori
skin
disord
skinbas
tumour
subject
review
innat
adapt
immun
system
induct
mainten
effect
cutan
immun
surveil
central
model
cutan
immun
surveil
cell
resid
skin
function
sentinel
danger
signal
includ
invas
microorgan
keratinocyt
langerhan
cell
epidermi
well
dermal
mast
cell
dendrit
danger
signal
cellwal
compon
product
pathogen
alert
innat
immun
system
presenc
potenti
harm
invad
usual
interact
tolllik
receptor
patternrecognit
receptor
express
tissu
cell
dendrit
cell
exampl
langerhan
figur
immunerespons
element
noninflam
skin
human
skin
compos
three
distinct
compart
relev
immun
function
first
epidermi
compos
keratin
epitheli
cell
function
physic
barrier
earli
warn
system
immun
cell
resid
epidermi
includ
special
dendrit
cell
dc
known
langerhan
cell
intraepitheli
lymphocyt
second
dermi
mainli
compos
connect
tissu
produc
dermal
fibroblast
immun
system
cell
resid
noninflam
dermi
includ
dermal
dc
mast
cell
small
number
cutan
lymphocyt
antigen
cla
posit
memori
cell
third
dermal
postcapillari
venul
constitut
express
low
level
eselectin
ccchemokin
ligand
intercellular
adhes
molecul
support
margin
baselin
emigr
cla
memori
cell
noninflam
skin
cla
cell
includ
naiv
cell
memoryeffector
cell
target
tissu
well
granulocyt
immun
cell
lack
appropri
receptor
attach
dermal
vessel
emigr
noninflam
skin
nonspecif
leukocyt
neutrophil
natur
killer
cell
well
key
compon
adapt
immun
system
effector
cell
fig
mast
cell
anoth
crucial
compon
cutan
immun
respons
apparatu
mast
cell
shown
releas
differ
pattern
cytokin
bioactiv
compound
includ
leukotrien
tnf
granulocytemacrophag
colonystimul
factor
gmcsf
respons
variou
tlr
ligand
mastcel
product
import
role
initi
modul
innat
immun
respons
gener
adapt
immun
respons
adapt
immun
system
base
cell
b
cell
express
antigenspecif
receptor
provid
vertebr
organ
broader
flexibl
repertoir
respons
pathogen
mean
provid
memori
past
encount
adapt
immun
surveil
address
logist
challeng
face
immun
system
get
right
cell
right
place
right
time
skin
interfac
process
view
oper
three
level
term
primari
secondari
tertiari
immun
surveil
fig
primari
immun
surveil
incorpor
mechan
bring
environment
antigen
encount
skin
profession
antigenpres
cell
apc
naiv
cell
togeth
special
microenviron
skindrain
lymph
node
secondari
immun
surveil
turn
involv
product
distribut
antigenspecif
effector
memori
cell
express
home
receptor
direct
migrat
tissu
antigen
encount
tertiari
immun
surveil
encompass
longterm
element
acquir
immun
respons
includ
product
central
memori
effector
cell
potenti
direct
tissu
site
primari
exposur
mode
immun
surveil
strategi
use
immun
system
improv
odd
cell
find
antigen
tcell
receptor
tcr
specif
develop
effect
respons
first
increas
effici
naiv
cell
expos
antigen
second
target
effector
respons
appropri
tissu
site
third
expand
coverag
tissu
primari
immun
surveil
activ
dc
whether
deriv
epiderm
langerhan
cell
dermal
dc
profession
apc
capac
present
antigen
effici
affect
matur
naiv
cell
memoryeffector
phenotyp
site
injuri
pathogen
invas
skin
cell
becom
activ
innat
mechan
includ
patternrecognit
receptor
tlr
exposur
proinflammatori
cytokin
tnf
releas
respons
tissu
injuri
infect
activ
apc
rapidli
engulf
foreign
particl
undergo
matur
emigr
affer
lymphat
activ
human
gene
regul
includ
endotheli
adhes
molecul
eselectin
pselectin
intercellular
adhes
molecul
vascular
celladhes
molecul
variou
chemokin
cytokin
collect
molecul
consid
necessari
suffici
initi
leukocyt
adhesionextravas
cascad
recruit
circul
leukocyt
peripheri
includ
antigen
activ
langerhan
cell
dermal
dc
stimul
matur
emigr
tissu
drain
lymph
node
carri
antigen
present
naiv
memori
cell
cytokin
chemokin
produc
respons
activ
cascad
act
local
endothelia
nuclear
mediat
pathway
upregul
express
adhes
molecul
includ
eselectin
pselectin
intercellular
adhes
molecul
direct
recruit
addit
innat
immun
compon
accord
specif
signal
gener
exampl
neutrophil
eosinophil
natur
killer
nk
cell
ccchemokin
ligand
wwwnaturecomreviewsimmunol
r
e
v
e
w
skin
carri
dc
migrat
affer
lymphat
adapt
immun
system
cell
enter
lymph
node
high
endotheli
venul
naiv
cell
encount
cognat
antigen
present
activ
matur
dc
undergo
prolifer
clonal
expans
produc
autocrin
growth
factor
differenti
memoryeffector
cell
antigen
encount
specif
tissu
skin
activ
cell
local
drain
lymph
node
result
product
antigenspecif
effector
cell
express
home
receptor
site
way
immun
respons
preferenti
target
back
site
initi
infect
stimul
cell
recruit
site
inflamm
skin
encount
rang
inflammatori
mediat
trigger
innat
immun
mechan
well
activ
dermal
dc
inflammatori
dendrit
epiderm
cell
idec
present
antigen
provid
costimulatori
signal
cell
express
appropri
counterreceptor
regard
recruit
cell
skin
earliest
step
process
tether
roll
cell
eselectin
andor
pselectin
express
dermal
postcapillari
venul
skinhom
cell
identifi
express
cellsurfac
carbohydr
epitop
cutan
lymphocyt
antigen
cla
bind
eselectin
cla
express
circul
memori
cell
virtual
absent
naiv
cell
cell
found
inflammatori
skin
lesion
mainli
cla
wherea
cell
accumul
inflammatori
site
skin
express
cla
cla
reproduc
found
cell
present
cutan
lymphocyt
infiltr
almost
skin
diseas
includ
psoriasi
atop
dermat
allerg
contact
dermat
erythema
multiform
cutan
graftversushost
diseas
gvhd
cutan
tcell
lymphoma
ctcl
biopsi
ctcl
malign
cell
respond
presenc
tumour
cell
skin
cla
cla
also
seem
good
marker
malign
ctcl
cell
peripher
blood
patient
sezari
syndrom
factor
induc
cla
express
cell
less
well
understood
seem
relat
special
environ
present
secondari
lymphoid
tissu
microenviron
skindrain
lymph
node
promot
express
cla
newli
activ
effector
cell
wherea
peyer
patch
exampl
favour
express
guthom
receptor
new
effector
cell
larg
volum
circumstanti
evid
support
model
exampl
circul
memori
cell
specif
nickel
housedust
mite
allerg
atop
individu
respect
express
high
level
cla
presum
antigen
encount
skin
similarli
circul
effector
cell
specif
skinassoci
virus
express
cla
wherea
specif
noncutan
virus
contrast
local
skindrain
lymph
node
matur
process
enhanc
antigen
process
upregul
express
mhc
molecul
costimulatori
molecul
includ
ref
function
local
drain
lymph
node
promot
frequent
supervis
contact
antigen
deriv
specif
segment
graftversushost
diseas
gvhd
tissu
damag
recipi
allogen
transplant
tissu
usual
bonemarrow
transplant
result
activ
donor
cytotox
lymphocyt
recogn
recipi
tissu
foreign
gvhd
vari
markedli
sever
life
threaten
sever
case
typic
damag
skin
gut
mucosa
lead
clinic
manifest
dermal
fibroblast
cla
effector
cell
cytokin
releas
keratinocyt
fibroblast
resid
antigenpres
cell
stimul
upregul
express
eselectin
intercellular
adhes
molecul
nuclear
mediat
activ
pathway
product
present
tcellspecif
chemokin
ccchemokin
ligand
local
endothelium
result
recruit
cla
cell
antigen
nonspecif
manner
cell
enter
tissu
encount
specif
antigen
present
local
macrophag
dendrit
cell
activ
prolifer
carri
specif
function
encount
cognat
antigen
might
cell
recruit
enter
lymphat
return
gener
circul
lc
langerhan
cell
associ
skinhom
cell
includ
ccchemokin
receptor
ligand
thymu
activationregul
chemokin
tarc
macrophagederiv
chemokin
mdc
constitut
induc
express
lumin
aspect
postcapillari
venul
skin
shown
cla
cell
typic
coexpress
interact
lead
arrest
roll
cell
provid
integrin
ligand
cutan
tcellattract
chemokin
ctack
also
implic
skin
home
chemokin
preferenti
produc
epiderm
keratinocyt
bind
chemotact
cell
vitro
express
subset
cla
cell
role
induc
arrest
cell
postcapillari
venul
skin
shown
work
indic
might
cell
specif
rotaviru
cla
express
high
level
ref
immun
system
encount
viru
gut
recent
mous
studi
indic
dc
deriv
peyer
patch
preferenti
induc
express
newli
gener
effector
cell
vitro
studi
cla
induct
vitro
indic
express
enhanc
activ
presenc
restrict
function
phenotyp
tcell
subset
howev
factor
regul
induct
express
vivo
mainten
express
rest
circul
cell
determin
although
cla
mediat
specif
tether
roll
step
distinct
tissu
vascular
bed
activ
roll
cell
also
proce
tissuespecif
manner
sever
chemokin
receptor
antigen
nonspecif
recruit
cla
effector
memori
cell
prime
skindrain
lymph
node
injuri
pathogen
figur
immunesurveil
mechan
skin
primari
immun
surveil
process
innat
immun
respons
ensur
effect
engag
adapt
immun
respons
antigen
encount
skin
carri
activ
dendrit
cell
affer
lymphat
drain
lymph
node
present
naiv
central
memori
cell
circul
node
increas
likelihood
encount
cell
express
appropri
tcell
receptor
tcr
cell
encount
cognat
antigen
prolifer
differenti
effector
cell
express
home
receptor
tissu
serv
node
b
secondari
immun
surveil
provid
mechan
ensur
rapid
effect
local
adapt
immun
respons
previous
encount
antigen
tissu
inflamm
result
upregul
express
adhes
molecul
present
specif
chemokin
local
endothelium
effector
memori
cell
express
appropri
counterreceptor
recruit
antigen
nonspecif
manner
cell
encount
cognat
antigen
present
local
antigenpres
cell
apc
particip
local
inflammatori
respons
wherea
return
gener
circul
c
tertiari
immun
surveil
repres
mechan
immun
system
hedg
bet
provid
enhanc
adapt
immun
respons
antigen
encount
tissu
distinct
previous
encount
central
memori
cell
produc
skindrain
lymph
node
express
lselectin
ccchemokin
receptor
allow
recircul
lymph
node
throughout
bodi
provid
enhanc
respons
antigen
encount
differ
environment
interfac
cla
cutan
lymphocyt
antigen
abil
circul
lymph
node
cell
emigr
lymph
node
origin
produc
lymph
node
throughout
bodi
includ
drain
noncutan
epithelialcel
interfac
may
encount
dc
express
cognat
antigen
way
immun
system
hedg
bet
ensur
rapid
effect
respons
even
next
encount
occur
differ
interfac
although
origin
descript
central
memori
cell
suggest
could
home
lymph
node
becom
clear
cell
express
central
memori
tissuehom
receptor
exampl
cell
express
cla
lselectin
well
repres
peripher
blood
one
interest
question
await
investig
whether
central
memori
cell
gener
skindrain
lymph
node
resid
differ
tissu
lymph
node
exampl
gut
respiratori
system
lymph
node
expos
antigen
give
rise
new
effector
skinhom
phenotyp
effector
home
current
sourc
tissu
seen
discuss
innat
immunesurveil
mechan
drive
develop
adapt
immun
respons
injuri
inflamm
danger
signal
facilit
tcell
develop
entri
tissu
memori
cell
innat
immun
effector
cell
thought
enter
tissu
see
antigen
local
endothelium
express
appropri
counterreceptor
chemoattract
exit
blood
respond
antigen
product
present
import
implic
aetiopatholog
inflammatori
skin
diseas
although
mechan
describ
earlier
highlight
activ
recruit
effector
cell
clear
regulatori
cell
also
import
though
less
well
character
role
dampen
exagger
cutan
immun
respons
well
mainten
immun
toler
innocu
self
exogen
antigen
recent
report
indic
regulatori
tcell
subset
might
traffic
skin
use
pathway
similar
use
effector
cell
imbal
effectorregulatori
tcell
recruit
function
might
crucial
factor
develop
inflammatori
skin
lesion
convers
condit
antigen
self
exogen
identifi
induct
regulatori
cell
specif
antigen
could
provid
power
mechan
induc
specif
toler
tcellmedi
inflammatori
skin
diseas
extraordinarili
common
also
new
therapi
diseas
led
new
tcellmedi
skin
diseas
notabl
gvhd
therapeut
allogen
bonemarrow
transplant
diseas
view
current
perspect
cutan
immun
surveil
insight
emerg
use
understand
clinic
biolog
behaviour
import
skin
home
though
express
chemokin
receptor
variabl
situat
seem
skinhom
memori
cell
express
cla
leukocyt
functionassoci
antigen
accumul
skin
eselectin
constitut
induc
express
postcapillari
venul
role
receptorligand
pair
specif
condit
remain
determin
cytokin
produc
cell
recruit
site
inflamm
influenc
content
ongo
infiltr
modifi
balanc
chemokin
produc
exampl
induc
keratinocyt
produc
rang
product
includ
ifninduc
protein
monokin
induc
mig
ifninduc
tcell
itac
act
recruit
cell
express
chemokin
receptor
ref
mani
pathogen
evolv
use
tissuespecif
rout
entri
persist
memori
cell
antigen
tissu
specif
peripher
circul
prepar
immun
system
possibl
futur
interact
pathogen
provid
popul
antigenspecif
effector
cell
pretarget
site
exposur
pathogen
would
like
recur
although
skinhom
cell
kind
rapid
deploy
corp
call
inflam
tissu
also
evid
constitut
home
cell
skin
cell
recov
noninflam
skin
express
high
level
cla
well
chemokin
receptor
even
absenc
inflamm
leukocyt
observ
tether
roll
constitut
low
level
selectin
express
dermal
postcapillari
venul
cell
thought
continu
scan
endothelialcel
surfac
target
tissu
activ
signal
pois
respond
slightest
hint
danger
constitut
express
eselectin
cutan
microvessel
describ
human
mice
express
ref
use
sequenti
interact
indetermin
fraction
cell
continu
enter
skin
traffic
seek
antigendepend
activ
antigenspecif
cell
also
detect
uninflam
skin
patient
atop
dermat
unclear
whether
cell
home
constitut
skin
respond
subclin
level
inflamm
altern
mechan
exist
support
constitut
express
endotheli
home
compon
import
note
skin
cell
thought
resid
cell
long
resid
skin
unknown
present
although
given
pathogen
like
reencount
epithelialcel
interfac
origin
engag
guarante
among
tcell
subpopul
produc
initi
antigen
encount
popul
antigenspecif
memori
cell
known
central
memori
cell
retain
express
ligand
regulatori
cell
type
cell
inhibit
effectortcel
activ
antigenspecif
manner
light
without
photosensit
psoralen
recent
immunobiolog
therapi
come
forefront
diseas
report
polar
therapi
inhibit
helper
cell
andor
enhanc
function
show
promis
biolog
agent
inhibit
tcell
recruit
activ
includ
alefacept
fusion
protein
efalizumab
human
antibodi
specif
cytotox
lymphocyt
antigen
immunoglobulin
fusion
protein
shown
efficaci
clinic
trial
alefacept
efalizumab
recent
win
fda
approv
biolog
agent
inhibit
tnf
also
quit
effect
etanercept
tnf
receptorigg
fc
fusion
protein
infliximab
human
monoclon
antibodi
specif
tnf
compound
shown
effect
treatment
psoriasi
interestingli
shortterm
treatment
antibodi
specif
eselectin
recent
shown
ineffect
psoriasi
indic
lesion
establish
block
tcell
roll
eselectin
insuffici
block
diseas
activ
contrast
efomycin
small
molecul
inhibitor
selectin
bind
recent
shown
effect
anim
model
psoriasi
might
indic
role
inhibit
selectin
treatment
human
psoriasi
interplay
innat
adapt
immun
respons
psoriasi
seen
koebner
phenomenon
physic
trauma
provok
develop
psoriat
lesion
discuss
earlier
skin
trauma
lead
releas
innat
immun
activ
tnf
result
upregul
eselectin
express
local
dermal
postcapillari
venul
lead
activ
resid
cell
recruit
cla
cell
blood
includ
presum
subpopul
specif
psoriat
autoantigen
innat
immun
activ
also
induc
matur
dc
dermi
epidermi
enhanc
activ
apc
encourag
activ
prolifer
recruit
cell
develop
psoriat
plaqu
evid
describ
earlier
indic
cutan
immunesurveil
system
respond
cutan
injuri
produc
danger
signal
potenti
infecti
innat
adapt
immun
mobil
activ
synergist
inappropri
adapt
immun
driven
nonspecif
activ
innat
immun
pathway
exampl
chronic
trauma
due
scratch
skin
turn
lead
autoinflammatori
feedback
loop
recruit
activ
leukocyt
independ
antigenspecif
help
differ
popul
cell
accumul
specif
diseas
state
reflect
pattern
express
vascular
adhes
molecul
chemoattract
cytokin
induc
balanc
stimuli
target
organ
tabl
potenti
signific
immunopatholog
diseas
organ
skin
continu
understand
mechan
cutan
immun
surveil
almost
certainli
provid
import
insight
immun
surveil
diseas
environment
epithelialcel
interfac
includ
gut
lung
oropharyng
genit
mucosa
psoriasi
psoriasi
affect
adult
worldwid
character
format
erythemat
cutan
plaqu
cover
scale
histolog
psoriat
plaqu
show
keratinocyt
hyperprolifer
neutrophil
infiltr
upper
epidermi
infiltr
dermi
epidermi
replet
cell
dc
macrophag
psoriasi
oblig
immunolog
compon
therapi
direct
tcell
activ
function
highli
effect
diseas
diseas
initi
xenograft
model
activ
cell
increasingli
understood
autoimmun
diseas
although
autoantigen
identifi
cell
psoriat
lesion
cla
produc
type
cytokin
profil
cell
particular
identifi
epidermi
thought
key
role
diseas
express
far
nearli
success
therapeut
intervent
psoriasi
target
cell
includ
corticosteroid
methotrex
cyclosporin
ultraviolet
helper
cell
h
type
cell
product
cytokin
stimul
cellular
immun
viral
bacteri
pathogen
wwwnaturecomreviewsimmunol
r
e
v
e
w
reaction
specif
environment
antigen
manifest
vari
degre
erythema
spongiosi
epiderm
oedema
vesicul
contact
allergen
irrit
exampl
uroshiol
poison
ivi
therefor
provid
antigen
danger
signal
contact
skin
pathophysiolog
disord
multifactori
character
infiltr
activ
cell
gener
model
allergenspecif
type
cell
act
effector
type
cell
act
regulatori
element
support
investig
anim
model
accumul
eosinophil
enhanc
product
ige
also
seen
acd
requir
sensit
phase
week
exposur
small
molecul
compon
activ
agent
bind
endogen
protein
act
hapten
induc
activ
prolifer
antigenspecif
cell
matur
skinhom
effector
memori
cell
subsequ
epicutan
exposur
result
symptom
progress
hour
day
reflect
activ
resid
antigenspecif
effector
cell
well
local
accumul
blood
follow
accumul
cell
produc
h
cytokin
exampl
chronic
resolv
lesion
recent
studi
implic
produc
regulatori
cell
key
factor
downmodul
allerg
respons
skin
acut
cutan
gvhd
describ
distinct
syndrom
dermat
develop
within
day
allogen
haematopoieticcel
transplant
chronic
cutan
gvhd
describ
indol
syndrom
develop
day
develop
gvhd
depend
transfer
immunolog
compet
cell
matur
cell
includ
bonemarrow
transplant
resid
solid
organ
transplant
presenc
alloantigen
host
tissu
stimul
graft
cell
lack
effect
host
immunolog
respons
graft
acut
cutan
gvhd
character
initi
rash
gener
red
skin
desquam
chronic
cutan
gvhd
lead
area
thicken
skin
sclerodermat
chang
sometim
caus
contractur
limit
joint
mobil
predilect
gvhd
skin
gastrointestin
tract
led
specul
mediat
respect
tissu
antigenspecif
cell
distinct
skinor
guthom
properti
hypothesi
formal
test
cutan
tcell
lymphoma
other
propos
ctcl
malign
skinhom
cell
common
form
uncommon
diseas
mycosi
fungoid
character
patch
plaqu
skin
often
nonsunexpos
area
resembl
eczemat
dermat
histopatholog
featur
ctcl
includ
cluster
malign
cell
epidermi
often
around
langerhan
cell
evid
atop
dermat
atop
dermat
common
diseas
affect
peopl
age
group
worldwid
preval
report
vari
children
individu
diseas
persist
adulthood
atopi
hereditari
predisposit
allergi
hypersensit
term
atop
dermat
use
describ
group
skin
diseas
associ
atop
condit
allerg
rhiniti
allerg
keratoconjunct
asthma
eczema
might
seen
age
group
clinic
atop
dermat
character
develop
erythemat
exud
lesion
skin
fold
associ
intens
itch
histopatholog
section
show
perivascular
infiltr
dermi
epidermi
lymphocyt
monocyt
macrophag
acut
atop
dermat
mediat
cell
specif
environment
antigen
although
subgroup
atop
dermat
might
differ
mechan
trigger
maintain
inflamm
exampl
extrinsicallerg
atop
dermat
versu
intrinsicnonallerg
atop
dermat
housedust
mite
dermatophagoid
pterynossinu
common
sourc
extrins
antigen
cell
specif
antigen
identifi
lesion
nonlesion
skin
select
individu
antigen
present
enhanc
presenc
highaffin
ige
receptor
langerhan
cell
intern
antibodyantigen
complex
process
antigen
present
cell
within
evolv
lesion
interestingli
atop
dermat
lesion
becom
chronic
cytokin
profil
exhibit
shift
h
h
type
mechan
behind
switch
incomplet
understood
interplay
innat
acquir
immun
emerg
diseas
also
well
establish
scratch
prurit
nonlesion
skin
lead
emerg
new
lesion
presum
occur
trauma
scratch
koebner
respons
describ
earlier
second
link
come
level
bacteri
colon
superinfect
staphylococcu
aureu
readili
cultur
atop
skin
particularli
lesion
skin
might
stimul
bacteri
superantigen
activ
tlr
resid
skin
cell
lead
chronic
releas
primari
cytokin
recent
studi
shown
atop
epidermi
unlik
psoriat
epidermi
produc
antibacteri
peptid
cathelicidin
respons
infect
block
induct
antimicrobi
peptid
keratinocyt
product
h
cell
block
one
pathway
innat
immun
activ
lead
bacteri
overgrowth
induct
anoth
innat
immun
pathway
turn
facilit
continu
activ
adapt
immun
system
includ
recruit
activ
atop
h
cell
perpetu
lesion
allerg
contact
dermat
allerg
contact
dermat
acd
also
refer
contact
hypersensit
tcellmedi
type
iv
delayedtyp
hypersensit
delayedtyp
hypersensit
cellular
immun
respons
antigen
develop
hour
infiltr
cell
monocyt
depend
product
cytokin
vitiligo
tcellmedi
autoimmun
disord
interestingli
vitiligo
promin
area
subject
minor
trauma
provid
anoth
diseaserel
link
innat
acquir
immun
inflammatori
skin
diseas
inflammatori
skin
disord
might
also
mediat
modul
mechan
although
data
present
literatur
investig
might
identifi
role
dysregul
leukocyt
home
pathogenesi
skin
condit
possibl
discuss
full
rang
implic
review
concept
immun
surveil
tissuespecif
home
import
implic
ration
design
vaccin
highlight
exampl
smallpox
box
must
antigen
administ
manner
lead
dc
matur
migrat
lymph
node
danger
signal
adjuv
effect
also
rout
administr
might
mark
qualit
quantit
effect
desir
protect
immun
respons
consider
take
broader
scope
purpos
interest
develop
vaccin
tumour
hiv
emerg
infecti
agent
respons
diseas
lyme
diseas
west
nile
viru
diseas
sever
acut
respiratori
syndrom
sar
even
longstand
immun
protocol
establish
year
ago
smallpox
activ
investig
improv
might
reduc
complic
maintain
effect
find
outlin
earlier
indic
vaccin
skin
intraderm
effici
stimul
skinhom
effector
cell
wherea
altern
rout
exampl
oral
intramuscular
effici
gener
effector
memori
cell
direct
toward
site
although
aggress
stimul
adjuv
might
bypass
anatom
specif
element
immun
respons
drive
broad
product
central
memori
cell
might
prefer
case
limit
respons
desir
site
avoid
potenti
complic
tissu
tumour
vaccin
knowledg
leukocyt
home
immunesurveil
mechan
also
implic
field
antitumour
vaccin
despit
consider
work
area
clinic
success
antitumor
vaccin
limit
far
one
reason
could
method
chosen
immun
insuffici
inappropri
tumour
interest
malign
melanoma
cancer
melanocyt
pigment
cell
resid
epidermi
hair
follicl
produc
melanin
convinc
evid
malign
melanoma
evok
humor
cellular
immun
respons
patient
radial
growth
phase
primari
melanoma
associ
slow
superfici
growth
without
promin
dermal
invas
regularli
associ
mark
dermal
lymphocyt
express
home
molecul
determin
anatom
local
cell
tumour
cell
cla
posit
lack
express
either
lselectin
found
skin
wherea
cell
express
lselectin
associ
lymphnod
involv
ctcl
cell
almost
invari
produc
h
cytokin
recent
evid
emerg
ctcl
associ
mark
disrupt
tcell
repertoir
indic
might
system
diseas
rather
simpli
clonal
malign
skinhom
cell
vitiligo
vitiligo
character
complet
partial
depigment
epidermi
acquir
progress
disord
melanocyt
resid
interfollicular
epidermi
occasion
hair
follicl
select
destroy
vitiligo
rel
frequent
occur
popul
cell
specif
antigen
uniqu
express
melanocyt
frequent
seen
patient
lead
suggest
box
vaccin
smallpox
atop
patient
smallpox
variola
major
typic
enter
host
oropharynx
invad
mucos
epithelium
migrat
region
lymph
node
spleen
bone
marrow
lymph
node
viral
replic
occur
incub
period
day
viru
enter
blood
within
leukocyt
seed
skin
produc
characterist
skin
lesion
pox
wherea
tissu
spare
fact
viru
seem
travel
leukocyt
specif
exit
blood
vessel
papillari
dermi
indic
variola
viru
preferenti
associ
leukocyt
home
skin
altern
might
skin
tissu
support
subsequ
replic
step
requir
lesion
format
protect
vaccin
vaccinia
viru
depend
deliveri
viru
epidermi
techniqu
known
scarif
lead
epiderm
pox
reaction
cutan
tcellmedi
delayedtyp
hypersensit
reaction
presum
involv
vacciniavirusspecif
skinhom
cell
subcutan
intramuscular
vaccin
fail
provok
pox
reaction
effect
incit
neutral
antibodi
vacciniavirusspecif
cytotox
cell
patient
either
activ
quiescent
atop
dermat
risk
immun
develop
eczema
vaccinatum
result
inabl
host
control
spread
viru
inocul
site
associ
substanti
morbid
mortal
ectromelia
mousepox
viru
genet
engin
produc
result
lethal
diseas
mice
normal
resist
unmodifi
ectromelia
indic
role
cytokin
restrict
immun
respons
pox
virus
product
h
cytokin
cytotox
tcell
function
also
impair
patient
atop
dermat
tcell
home
might
dysfunct
patient
well
mice
gener
h
h
cytokin
associ
skinhom
phenotyp
presenc
skinhom
h
cell
atop
patient
might
repres
uncoupl
associ
surprisingli
even
innat
immun
might
impair
patient
product
increas
atop
dermat
keratinocyt
patient
atop
dermat
produc
differ
array
cytokin
chemokin
keratinocyt
nonatop
individu
protocol
enhanc
dc
migrat
peripher
lymph
node
investig
also
import
consid
effect
vaccin
strategi
dc
activ
antigen
present
immatur
dc
shown
stimul
antigenspecif
inhibit
effector
tcell
function
investig
leukocyt
traffick
skin
provid
insight
role
primari
secondari
tertiari
immun
surveil
normal
cutan
immun
function
develop
inflammatori
skin
diseas
disord
discuss
detail
subset
clinic
import
tcellmedi
skin
diseas
also
includ
drug
erupt
alopecia
areata
lichen
planu
mani
other
number
divers
diseas
testament
mani
thing
potenti
go
wrong
complex
system
cutan
immun
surveil
time
extraordinari
cutan
immun
system
work
well
time
concept
exagger
inappropri
activ
import
immunesurveil
mechan
caus
organspecif
diseas
might
extend
inflammatori
bowel
diseas
asthma
occur
two
epithelialcel
interfac
environ
challeng
design
therapi
target
element
cutan
immun
surveil
overact
specif
diseas
skin
organ
leav
intact
function
central
surviv
hostil
world
fill
opportunist
pathogen
reaction
sometim
result
partial
tumour
destruct
clonal
expans
cell
occur
regress
primari
melanoma
lymphocyt
explant
lesion
cytotox
vitro
autolog
melanoma
cell
although
rapid
lymphocyt
infiltr
vertic
growth
phase
rapid
growth
promin
dermal
invas
occur
primari
melanoma
occur
less
frequent
respons
correl
prolong
surviv
reduc
incid
metastat
diseas
mani
strategi
enhanc
antimelanoma
immun
investig
present
base
whole
tumour
cell
defin
tumour
antigen
develop
protocol
rel
littl
attent
paid
rout
vaccin
use
would
predict
immun
skin
would
gener
skinhom
effector
tcell
respons
might
expect
target
metastat
tumour
lung
gastrointestin
tract
effici
normal
circumst
antimelanoma
tcell
respons
might
first
expect
develop
local
skindrain
lymph
node
lead
gener
skinhom
memori
effector
cell
inde
therapi
expand
activ
preexist
memori
effector
cell
popul
dc
vaccin
therapi
result
rapid
respons
cutan
metastas
melanoma
metastas
elsewher
immun
melanomaantigenpuls
dc
inject
skin
could
traffic
affer
lymphat
drain
lymph
node
gener
skinhom
memori
effector
cell
inject
intraven
howev
migrat
pattern
remain
larg
unknown
